Title: Small-molecular tyrosine kinase inhibitors targeting vascular endothelial growth factor receptor-2 in the treatment of non-small cell lung cancer
Abstract: Lung cancer is the leading cause of cancer-related death all around the world.Non-small cell lung cancer (NSCLC) accounts for almost 87% of all lung cancers. It has been well established that tumor angiogenesis is one of major mechanisms of tumor progression. Vascular endothelial growth factor receptor (VEGFR) signal pathway may be the dominant pathway involved in tumor angiogenesis, while the VEGFR-2 is now believed to the most important member of the VEGFR family
Publication Year: 2015
Publication Date: 2015-02-07
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot